We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Fights FTC Move to Expand Antitrust Reviews of Patent Transfers
PhRMA Fights FTC Move to Expand Antitrust Reviews of Patent Transfers
A court battle is heating up between PhRMA and the Federal Trade Commission over the FTC’s new rule expanding antitrust reviews of post-merger patent transfers, and the fees associated with the expanded reviews.